Neuronal intermediate filaments and ALS: A new look at an old question

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 11-12, 2006, Pages 1001-1012

  Xiao, Shangxi ^a   McLean, Jesse ^a   Robertson, Janice ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Intermediate filament; Neurofilament; Peripherin

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN; NEUROFILAMENT PROTEIN; PERIPHERIN;

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENETIC HETEROGENEITY; HUMAN; MOLECULAR BIOLOGY; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; INCLUSION BODIES; INTERMEDIATE FILAMENT PROTEINS; INTERMEDIATE FILAMENTS; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MOTOR NEURON DISEASE; MOTOR NEURONS; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; PHOSPHORYLATION;

EID: 33751243629     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.09.003     Document Type: Review

References (181)

1. Ackerley S., Grierson A.J., Brownlees J., Thornhill P., Anderton B.H., Leigh P.N., Shaw C.E., and Miller C.C. Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol. 150 (2000) 165-176
2. Ackerley S., Thornhill P., Grierson A.J., Brownlees J., Anderton B.H., Leigh P.N., Shaw C.E., and Miller C.C. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 161 (2003) 489-495
3. Al-Chalabi A., Andersen P.M., Nilsson P., Chioza B., Andersson J.L., Russ C., Shaw C.E., Powell J.F., and Leigh P.N. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet. 8 (1999) 157-164
4. Al-Chalabi A., and Miller C.C. Neurofilaments and neurological disease. BioEssays 25 (2003) 346-355
5. Beaulieu J.M., Jacomy H., and Julien J.P. Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J. Neurosci. 20 (2000) 5321-5328
6. Beaulieu J.M., Kriz J., and Julien J.P. Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia. Brain Res. 946 (2002) 153-161
7. Beaulieu J.M., Nguyen M.D., and Julien J.P. Late onset of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 147 (1999) 531-544
8. Beaulieu J.M., Robertson J., and Julien J.P. Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits. Biochem. Cell. Biol. 77 (1999) 41-45
9. Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M.J., and Percy M.E. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53 (1994) 221-230
10. Brenner M., Johnson A.B., Boespflug-Tanguy O., Rodriguez D., Goldman J.E., and Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27 (2001) 117-120
11. Brody B.A., Ley C.A., and Parysek L.M. Selective distribution of the 57 kDa neural intermediate filament protein in the rat CNS. J. Neurosci. 9 (1989) 2391-2401
12. Brownlees J., Ackerley S., Grierson A.J., Jacobsen N.J., Shea K., Anderton B.H., Leigh P.N., Shaw C.E., and Miller C.C. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet. 11 (2002) 2837-2844
13. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
14. Bunina T.L. On intracellular inclusions in familial amyotrophic lateral sclerosis. Zh Nevropatol Psikhiatr Im S S Korsakova 62 (1962) 1293-1299
15. Cairns N.J., Uryu K., Bigio E.H., Mackenzie I.R., Gearing M., Duyckaerts C., Yokoo H., Nakazato Y., Jaros E., Perry R.H., Arnold S.E., Lee V.M., and Trojanowski J.Q. alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases. Acta Neuropathol. (Berl) 108 (2004) 213-223
16. Canete-Soler R., Schwartz M.L., Hua Y., and Schlaepfer W.W. Stability determinants are localized to the 3′-untranslated region and 3′-coding region of the neurofilament light subunit mRNA using a tetracycline-inducible promoter. J. Biol. Chem. 273 (1998) 12650-12654
17. Canete-Soler R., Silberg D.G., Gershon M.D., and Schlaepfer W.W. Mutation in neurofilament transgene implicates RNA processing in the pathogenesis of neurodegenerative disease. J. Neurosci. 19 (1999) 1273-1283
18. Carden M.J., Schlaepfer W.W., and Lee V.M. The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state. J. Biol. Chem. 260 (1985) 9805-9817
19. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 18 (1968) 841-851
20. Chang L., and Goldman R.D. Intermediate filaments mediate cytoskeletal crosstalk. Nat. Rev., Mol. Cell Biol. 5 (2004) 601-613
21. Chevalier-Larsen E., and Holzbaur E.L. Axonal transport and nuerodegenerative disease. Biochim. Biophys. Acta 1762 (2006) 1094-1108
22. Ching G.Y., Chien C.L., Flores R., and Liem R.K. Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice. J. Neurosci. 19 (1999) 2974-2986
23. Ching G.Y., and Liem R.K. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122 (1993) 1323-1335
24. Chou Y.H., Rosevear E., and Goldman R.D. Phosphorylation and disassembly of intermediate filaments in mitotic cells. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 1885-1889
25. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown Jr. R.H., Julien J.P., Goldstein L.S., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
26. Collard J.F., Cote F., and Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375 (1995) 61-64
27. Corbo M., and Hays A.P. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol. 51 (1992) 531-537
28. Couillard-Despres S., Zhu Q., Wong P.C., Price D.L., Cleveland D.W., and Julien J.P. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9626-9630
29. Coulombe P.A., Ma L., Yamada S., and Wawersik M. Intermediate filaments at a glance. J. Cell. Sci. 114 (2001) 4345-4347
30. Coulombe P.A., and Wong P. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat. Cell Biol. 6 (2004) 699-706
31. Cui C., Stambrook P.J., and Parysek L.M. Peripherin assembles into homopolymers in SW13 cells. J. Cell. Sci. 108 Pt 10 (1995) 3279-3284
32. Dalakas M.C., Park K.Y., Semino-Mora C., Lee H.S., Sivakumar K., and Goldfarb L.G. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N. Engl. J. Med. 342 (2000) 770-780
33. De Jonghe P., Mersivanova I., Nelis E., Del Favero J., Martin J.J., Van Broeckhoven C., Evgrafov O., and Timmerman V. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol. 49 (2001) 245-249
34. de Waegh S.M., Lee V.M., and Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68 (1992) 451-463
35. Djabali K., Zissopoulou A., de Hoop M.J., Georgatos S.D., and Dotti C.G. Peripherin expression in hippocampal neurons induced by muscle soluble factor(s). J. Cell Biol. 123 (1993) 1197-1206
36. Dong D.L., Xu Z.S., Chevrier M.R., Cotter R.J., Cleveland D.W., and Hart G.W. Glycosylation of mammalian neurofilaments. Localiztion of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. J. Biol. Chem. 268 (1993) 16679-16687
37. Dong D.L., Xu Z.S., Hart G.W., and Cleveland D.W. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H. J. Biol. Chem. 271 (1996) 20845-20852
38. Fabrizi G.M., Cavallaro T., Angiari C., Bertolasi L., Cabrini I., Ferrarini M., and Rizzuto N. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology 62 (2004) 1429-1431
39. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., and Julien J.P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3 (1994) 1757-17561
40. Fuchs E. The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu. Rev. Genet. 30 (1996) 197-231
41. Fuchs E., and Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease. Science 279 (1998) 514-519
42. Fuchs E., and Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 63 (1994) 345-382
43. Gallo J.M., Jin P., Thornton C.A., Lin H., Robertson J., D'Souza I., and Schlaepfer W.W. The role of RNA and RNA processing in neurodegeneration. J. Neurosci. 25 (2005) 10372-10375
44. Garcia M.L., Lobsiger C.S., Shah S.B., Deerinck T.J., Crum J., Young D., Ward C.M., Crawford T.O., Gotow T., Uchiyama Y., Ellisman M.H., Calcutt N.A., and Cleveland D.W. NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth. J. Cell Biol. 163 (2003) 1011-1020
45. Garcia M.L., Singleton A.B., Hernandez D., Ward C.M., Evey C., Sapp P.A., Hardy J., Brown Jr. R.H., and Cleveland D.W. Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis. Neurobiol. Dis. 21 (2006) 102-109
46. Georgiou D.M., Zidar J., Korosec M., Middleton L.T., Kyriakides T., and Christodoulou K. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4 (2002) 93-96
47. Giasson B.I., Cromlish J.A., Athlan E.S., and Mushynski W.E. Activation of cyclic AMP-dependent protein kinase in okadaic acid-treated neurons potentiates neurofilament fragmentation and stimulates phosphorylation of Ser2 in the low-molecular-mass neurofilament subunit. J. Neurochem. 66 (1996) 1207-1213
48. Gibb B.J., Brion J.P., Brownlees J., Anderton B.H., and Miller C.C. Neuropathological abnormalities in transgenic mice harbouring a phosphorylation mutant neurofilament transgene. J. Neurochem. 70 (1998) 492-500
49. Gibb B.J., Robertson J., and Miller C.C. Assembly properties of neurofilament light chain Ser55 mutants in transfected mammalian cells. J. Neurochem. 66 (1996) 1306-1311
50. Gill S.R., Wong P.C., Monteiro M.J., and Cleveland D.W. Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit. J. Cell Biol. 111 (1990) 2005-2019
51. Goldfarb L.G., Park K.Y., Cervenakova L., Gorokhova S., Lee H.S., Vasconcelos O., Nagle J.W., Semino-Mora C., Sivakumar K., and Dalakas M.C. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat. Genet. 19 (1998) 402-403
52. Goldstein M.E., Grant P., House S.B., Henken D.B., and Gainer H. Developmental regulation of two distinct neuronal phenotypes in rat dorsal root ganglia. Neuroscience 71 (1996) 243-258
53. Goldstein M.E., House S.B., and Gainer H. NF-L and peripherin immunoreactivities define distinct classes of rat sensory ganglion cells. J. Neurosci. Res. 30 (1991) 92-104
54. Gonda Y., Nishizawa K., Ando S., Kitamura S., Minoura Y., Nishi Y., and Inagaki M. Involvement of protein kinase C in the regulation of assembly-disassembly of neurofilaments in vitro. Biochem. Biophys. Res. Commun. 167 (1990) 1316-1325
55. Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., and Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20 (2000) 660-665
56. Goudeau B., Dagvadorj A., Rodrigues-Lima F., Nedellec P., Casteras-Simon M., Perret E., Langlois S., Goldfarb L., and Vicart P. Structural and functional analysis of a new desmin variant causing desmin-related myopathy. Human Mutat. 18 (2001) 388-396
57. Grant P., and Pant H.C. Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 29 (2000) 843-872
58. Green S.L., Westendorf J.M., Jaffe H., Pant H.C., Cork L.C., Ostrander E.A., Vignaux F., and Ferrell Jr. J.E. Allelic variants of the canine heavy neurofilament (NFH) subunit and extensive phosphorylation in dogs with motor neuron disease. J. Comp. Pathol. 132 (2005) 33-50
59. Gros-Louis F., Lariviere R., Gowing G., Laurent S., Camu W., Bouchard J.P., Meininger V., Rouleau G.A., and Julien J.P. A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J. Biol. Chem. 279 (2004) 45951-45956
60. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., Morgan P.J., Oozageer R., Priestley J.V., Averill S., King V.R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus D., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., Hrabe de Angelis M., Schiavo G., Shima D.T., Russ A.P., Stumm G., Martin J.E., and Fisher E.M. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003) 808-812
61. Hays A.P. The Pathology of Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis vol. 1 (2006), Taylor and Francis, New York 43-80
62. Hays A.P., Naini A., He C.Z., Mitsumoto H., and Rowland L.P. Sporadic amyotrophic lateral sclerosis and breast cancer: Hyaline conglomerate inclusions lead to identification of SOD1 mutation. J. Neurol. Sci. 242 (2006) 67-69
63. He C.Z., and Hays A.P. Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis. J. Neurol. Sci. 217 (2004) 47-54
64. Helfand B.T., Chang L., and Goldman R.D. Intermediate filaments are dynamic and motile elements of cellular architecture. J. Cell. Sci. 117 (2004) 133-141
65. Hesse M., Magin T.M., and Weber K. Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18. J. Cell. Sci. 114 (2001) 2569-2575
66. Hirano A. Cytopathology of amyotrophic lateral sclerosis. Adv. Neurol. 56 (1991) 91-101
67. Hirano A., Donnenfeld H., Sasaki S., and Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43 (1984) 461-470
68. Hisanaga S., Gonda Y., Inagaki M., Ikai A., and Hirokawa N. Effects of phosphorylation of the neurofilament L protein on filamentous structures. Cell Regul. 1 (1990) 237-248
69. Hisanaga S., and Hirokawa N. Structure of the peripheral domains of neurofilaments revealed by low angle rotary shadowing. J. Mol. Biol. 202 (1988) 297-305
70. Ho C.L., Chin S.S., Carnevale K., and Liem R.K. Translation initiation and assembly of peripherin in cultured cells. Eur. J. Cell Biol. 68 (1995) 103-112
71. Ince P.G., Lowe J., and Shaw P.J. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol. Appl. Neurobiol. 24 (1998) 104-117
72. Izawa I., and Inagaki M. Regulatory mechanisms and functions of intermediate filaments: a study using site- and phosphorylation state-specific antibodies. Cancer Sci. 97 (2006) 167-174
73. Jordanova A., De Jonghe P., Boerkoel C.F., Takashima H., De Vriendt E., Ceuterick C., Martin J.J., Butler I.J., Mancias P., Papasozomenos S., Terespolsky D., Potocki L., Brown C.W., Shy M., Rita D.A., Tournev I., Kremensky I., Lupski J.R., and Timmerman V. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126 (2003) 590-597
74. Julien J.P., and Kriz J. Transgenic mouse models of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762 (2006) 1013-1024
75. Julien J.P., and Mushynski W.E. The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments. J. Biol. Chem. 258 (1983) 4019-4025
76. Julien J.P., and Mushynski W.E. Multiple phosphorylation sites in mammalian neurofilament polypeptides. J. Biol. Chem. 257 (1982) 10467-10470
77. Julien J.P., and Mushynski W.E. Neurofilaments in health and disease. Prog. Nucleic Acid Res. Mol. Biol. 61 (1998) 1-23
78. Jung C., Lee S., Ortiz D., Zhu Q., Julien J.P., and Shea T.B. The high and middle molecular weight neurofilament subunits regulate the association of neurofilaments with kinesin: inhibition by phosphorylation of the high molecular weight subunit. Brain Res. Mol. Brain Res. 141 (2005) 151-155
79. Kato T., Katagiri T., Hirano A., Kawanami T., and Sasaki H. Lewy body-like hyaline inclusions in sporadic motor neuron disease are ubiquitinated. Acta Neuropathol. (Berl) 77 (1989) 391-396
80. Kato T., Kurita K., Seino T., Kadoya T., Horie H., Wada M., Kawanami T., Daimon M., and Hirano A. Galectin-1 is a component of neurofilamentous lesions in sporadic and familial amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 282 (2001) 166-172
81. Kim S., Wong P., and Coulombe P.A. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 441 (2006) 362-365
82. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., and Holzbaur E.L. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002) 715-727
83. Landon F., Lemonnier M., Benarous R., Huc C., Fiszman M., Gros F., and Portier M.M. Multiple mRNAs encode peripherin, a neuronal intermediate filament protein. EMBO J. 8 (1989) 1719-1726
84. Landon F., Wolff A., and de Nechaud B. Mouse peripherin isoforms. Biol. Cell 92 (2000) 397-407
85. Lariviere R.C., Beaulieu J.M., Nguyen M.D., and Julien J.P. Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase. Neurobiol. Dis. 13 (2003) 158-166
86. Lariviere R.C., and Julien J.P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58 (2004) 131-148
87. Lariviere R.C., Nguyen M.D., Ribeiro-da-Silva A., and Julien J.P. Reduced number of unmyelinated sensory axons in peripherin null mice. J. Neurochem. 81 (2002) 525-532
88. Lavedan C., Buchholtz S., Nussbaum R.L., Albin R.L., and Polymeropoulos M.H. A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neurosci. Lett. 322 (2002) 57-61
89. Lecomte M.J., Basseville M., Landon F., Karpov V., and Fauquet M. Transcriptional activation of the mouse peripherin gene by leukemia inhibitory factor: involvement of STAT proteins. J. Neurochem. 70 (1998) 971-982
90. Lee M.K., and Cleveland D.W. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr. Opin. Cell Biol. 6 (1994) 34-40
91. Lee M.K., Marszalek J.R., and Cleveland D.W. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13 (1994) 975-988
92. Lee M.K., Xu Z., Wong P.C., and Cleveland D.W. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122 (1993) 1337-1350
93. Leigh P.N., Anderton B.H., Dodson A., Gallo J.M., Swash M., and Power D.M. Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci. Lett. 93 (1988) 197-203
94. Leigh P.N., Whitwell H., Garofalo O., Buller J., Swash M., Martin J.E., Gallo J.M., Weller R.O., and Anderton B.H. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114 Pt 2 (1991) 775-788
95. Leonard D.G., Gorham J.D., Cole P., Greene L.A., and Ziff E.B. A nerve growth factor-regulated messenger RNA encodes a new intermediate filament protein. J. Cell Biol. 106 (1988) 181-193
96. Letournel F., Bocquet A., Dubas F., Barthelaix A., and Eyer J. Stable tubule only polypeptides (STOP) proteins co-aggregate with spheroid neurofilaments in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 62 (2003) 1211-1219
97. Leung C.L., He C.Z., Kaufmann P., Chin S.S., Naini A., Liem R.K., Mitsumoto H., and Hays A.P. A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol. 14 (2004) 290-296
98. Leung C.L., Nagan N., Graham T.H., and Liem R.K. A novel duplication/insertion mutation of NEFL in a patient with Charcot-Marie-Tooth disease. Am. J. Med. Genet. 140 (2006) 1021-1025
99. Li D., Tapscoft T., Gonzalez O., Burch P.E., Quinones M.A., Zoghbi W.A., Hill R., Bachinski L.L., Mann D.L., and Roberts R. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100 (1999) 461-464
100. Li R., Messing A., Goldman J.E., and Brenner M. GFAP mutations in Alexander disease. Int. J. Dev. Neurosci. 20 (2002) 259-268
101. Lin H., Zhai J., Canete-Soler R., and Schlaepfer W.W. 3′ untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells. J. Neurosci. 24 (2004) 2716-2726
102. Lin H., Zhai J., and Schlaepfer W.W. RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration. Hum. Mol. Genet. 14 (2005) 3643-3659
103. Lobsiger C.S., Garcia M.L., Ward C.M., and Cleveland D.W. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10351-10356
104. Lowe J., Blanchard A., Morrell K., Lennox G., Reynolds L., Billett M., Landon M., and Mayer R.J. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J. Pathol. 155 (1988) 9-15
105. Ludemann N., Clement A., Hans V.H., Leschik J., Behl C., and Brandt R. O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). J. Biol. Chem. 280 (2005) 31648-31658
106. Manetto V., Sternberger N.H., Perry G., Sternberger L.A., and Gambetti P. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 47 (1988) 642-653
107. Matsumoto S., Kusaka H., Ito H., Shibata N., Asayama T., and Imai T. Sporadic amyotrophic lateral sclerosis with dementia and Cu/Zn superoxide dismutase-positive Lewy body-like inclusions. Clin. Neuropathol. 15 (1996) 41-46
108. Mersiyanova I.V., Perepelov A.V., Polyakov A.V., Sitnikov V.F., Dadali E.L., Oparin R.B., Petrin A.N., and Evgrafov O.V. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67 (2000) 37-46
109. Migheli A., Pezzulo T., Attanasio A., and Schiffer D. Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab. Invest. 68 (1993) 185-191
110. Miller C.C., Ackerley S., Brownlees J., Grierson A.J., Jacobsen N.J., and Thornhill P. Axonal transport of neurofilaments in normal and disease states. Cell. Mol. Life Sci. 59 (2002) 323-330
111. Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., and Okamoto K. Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl) (2006) [Electronic publication ahead of print 2006 Aug 5]
112. Mizusawa H., Nakamura H., Wakayama I., Yen S.H., and Hirano A. Skein-like inclusions in the anterior horn cells in motor neuron disease. J. Neurol. Sci. 105 (1991) 14-21
113. Motil J., Chan W.K., Dubey M., Chaudhury P., Pimenta A., Chylinski T.M., Ortiz D.T., and Shea T.B. Dynein mediates retrograde neurofilament transport within axons and anterograde delivery of NFs from perikarya into axons: regulation by multiple phosphorylation events. Cell Motil. Cytoskelet. 63 (2006) 266-286
114. Munoz-Marmol A.M., Strasser G., Isamat M., Coulombe P.A., Yang Y., Roca X., Vela E., Mate J.L., Coll J., Fernandez-Figueras M.T., Navas-Palacios J.J., Ariza A., and Fuchs E. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11312-11317
115. Nakagawa T., Chen J., Zhang Z., Kanai Y., and Hirokawa N. Two distinct functions of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: cross-bridge formation and longitudinal elongation of filaments. J. Cell Biol. 129 (1995) 411-429
116. Nakamura Y., Takeda M., Angelides K.J., Tanaka T., Tada K., and Nishimura T. Effect of phosphorylation on 68 kDa neurofilament subunit protein assembly by the cyclic AMP dependent protein kinase in vitro. Biochem. Biophys. Res. Commun. 169 (1990) 744-750
117. Nie Z., Wu J., Zhai J., Lin H., Ge W., Schlaepfer W.W., and Canete-Soler R. Untranslated element in neurofilament mRNA has neuropathic effect on motor neurons of transgenic mice. J. Neurosci. 22 (2002) 7662-7670
118. Niwa J., Ishigaki S., Hishikawa N., Yamamoto M., Doyu M., Murata S., Tanaka K., Taniguchi N., and Sobue G. Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J. Biol. Chem. 277 (2002) 36793-36798
119. Nixon R.A., and Shea T.B. Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motil. Cytoskelet. 22 (1992) 81-91
120. Nixon R.A., and Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 14 (1991) 501-506
121. Okamoto K., Hirai S., Amari M., Watanabe M., and Sakurai A. Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum. Neurosci. Lett. 162 (1993) 125-128
122. Omary M.B., Coulombe P.A., and McLean W.H. Intermediate filament proteins and their associated diseases. N. Engl. J. Med. 351 (2004) 2087-2100
123. Omary M.B., Ku N.O., Tao G.Z., Toivola D.M., and Liao J. 'Heads and tails' of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 31 (2006) 383-394
124. Paramio J.M., and Jorcano J.L. Beyond structure: do intermediate filaments modulate cell signalling?. BioEssays 24 (2002) 836-844
125. Park K.Y., Dalakas M.C., Goebel H.H., Ferrans V.J., Semino-Mora C., Litvak S., Takeda K., and Goldfarb L.G. Desmin splice variants causing cardiac and skeletal myopathy. J. Med. Genet. 37 (2000) 851-857
126. Park K.Y., Dalakas M.C., Semino-Mora C., Lee H.S., Litvak S., Takeda K., Ferrans V.J., and Goldfarb L.G. Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation. Clin. Genet. 57 (2000) 423-429
127. Parry D.A., and Steinert P.M. Intermediate filaments: molecular architecture, assembly, dynamics and polymorphism. Q. Rev. Biophys. 32 (1999) 99-187
128. Parysek L.M., and Goldman R.D. Distribution of a novel 57 kDa intermediate filament (IF) protein in the nervous system. J. Neurosci. 8 (1988) 555-563
129. Parysek L.M., McReynolds M.A., Goldman R.D., and Ley C.A. Some neural intermediate filaments contain both peripherin and the neurofilament proteins. J. Neurosci. Res. 30 (1991) 80-91
130. Perez-Olle R., Jones S.T., and Liem R.K. Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. Hum. Mol. Genet. 13 (2004) 2207-2220
131. Perez-Olle R., Leung C.L., and Liem R.K. Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J. Cell. Sci. 115 (2002) 4937-4946
132. Perez-Olle R., Lopez-Toledano M.A., Goryunov D., Cabrera-Poch N., Stefanis L., Brown K., and Liem R.K. Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J. Neurochem. 93 (2005) 861-874
133. Piao Y.S., Wakabayashi K., Kakita A., Yamada M., Hayashi S., Morita T., Ikuta F., Oyanagi K., and Takahashi H. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol. 13 (2003) 10-22
134. Portier M.M., Brachet P., Croizat B., and Gros F. Regulation of peripherin in mouse neuroblastoma and rat PC 12 pheochromocytoma cell lines. Dev. Neurosci. 6 (1983) 215-226
135. Portier M.M., de Nechaud B., and Gros F. Peripherin, a new member of the intermediate filament protein family. Dev. Neurosci. 6 (1983) 335-344
136. Portier M.M., Escurat M., Landon F., Djabali K., and Bousquet O. Peripherin and neurofilaments: expression and role during neural development. C. R. Acad. Sci. III 316 (1993) 1124-1140
137. Prahlad V., Helfand B.T., Langford G.M., Vale R.D., and Goldman R.D. Fast transport of neurofilament protein along microtubules in squid axoplasm. J. Cell. Sci. 113 Pt 22 (2000) 3939-3946
138. Rakhit R., and Chakrabartty A. Structure, folding, and misfolding of Cu, Zn superoxide dismutase in amyotrophic lateral sclerosis. Biochim, Biophys. Acta 1762 (2006) 1025-1037
139. Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X.F., Crow J.P., Cashman N.R., Kondejewski L.H., and Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 277 (2002) 47551-47556
140. Rao M.V., Garcia M.L., Miyazaki Y., Gotow T., Yuan A., Mattina S., Ward C.M., Calcutt N.A., Uchiyama Y., Nixon R.A., and Cleveland D.W. Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport. J. Cell Biol. 158 (2002) 681-693
141. Rao M.V., Houseweart M.K., Williamson T.L., Crawford T.O., Folmer J., and Cleveland D.W. Neurofilament-dependent radial growth of motor axons and axonal organization of neurofilaments does not require the neurofilament heavy subunit (NF-H) or its phosphorylation. J. Cell Biol. 143 (1998) 171-181
142. Robertson J., Beaulieu J.M., Doroudchi M.M., Durham H.D., Julien J.P., and Mushynski W.E. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J. Cell Biol. 155 (2001) 217-226
143. Robertson J., Doroudchi M.M., Nguyen M.D., Durham H.D., Strong M.J., Shaw G., Julien J.P., and Mushynski W.E. A neurotoxic peripherin splice variant in a mouse model of ALS. J. Cell Biol. 160 (2003) 939-949
144. Robertson J., and Julien J.P. Cytoskeletal abnormalities in ALS/MND. In: Shaw P.J., and Strong M.J. (Eds). Motor Neuron Disorders, Blue Books of Practical Neurology (2003), Butterworth Heinemann, Philadelphia 315-339
145. Roy S., Coffee P., Smith G., Liem R.K., Brady S.T., and Black M.M. Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J. Neurosci. 20 (2000) 6849-6861
146. Sasaki S., and Maruyama S. Ultrastructural study of skein-like inclusions in anterior horn neurons of patients with motor neuron disease. Neurosci. Lett. 147 (1992) 121-124
147. Sasaki S., Maruyama S., Yamane K., Sakuma H., and Takeishi M. Swellings of proximal axons in a case of motor neuron disease. Ann. Neurol. 25 (1989) 520-522
148. Sasaki S., Toi S., Shirata A., Yamane K., Sakuma H., and Iwata M. Immunohistochemical and ultrastructural study of basophilic inclusions in adult-onset motor neuron disease. Acta Neuropathol. (Berl) 102 (2001) 200-206
149. Sasaki T., Gotow T., Shiozaki M., Sakaue F., Saito T., Julien J.P., Uchiyama Y., and Hisanaga S. Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants. Hum. Mol. Genet. 15 (2006) 943-952
150. Shah J.V., Flanagan L.A., Janmey P.A., and Leterrier J.F. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. Mol. Biol. Cell 11 (2000) 3495-3508
151. Shea T.B., and Flanagan L.A. Kinesin, dynein and neurofilament transport. Trends Neurosci. 24 (2001) 644-648
152. Shea T.B., Jung C., and Pant H.C. Does neurofilament phosphorylation regulate axonal transport?. Trends Neurosci. 26 (2003) 397-400
153. Shibata N., Hirano A., Kobayashi M., Sasaki S., Kato T., Matsumoto S., Shiozawa Z., Komori T., Ikemoto A., Umahara T., et al. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci. Lett. 179 (1994) 149-152
154. Sihag R.K., and Nixon R.A. Identification of Ser-55 as a major protein kinase A phosphorylation site on the 70-kDa subunit of neurofilaments. Early turnover during axonal transport. J. Biol. Chem. 266 (1991) 18861-18867
155. Sihag R.K., and Nixon R.A. In vivo phosphorylation of distinct domains of the 70-kilodalton neurofilament subunit involves different protein kinases. J. Biol. Chem. 264 (1989) 457-464
156. Sjoberg G., Saavedra-Matiz C.A., Rosen D.R., Wijsman E.M., Borg K., Horowitz S.H., and Sejersen T. A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum. Mol. Genet. 8 (1999) 2191-2198
157. Skalli O., Chou Y.H., and Goldman R.D. Intermediate filaments: not so tough after all. Trends Cell Biol. 2 (1992) 308-312
158. Sternberger N.H., Sternberger L.A., and Ulrich J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4274-4276
159. Sterneck E., Kaplan D.R., and Johnson P.F. Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. J. Neurochem. 67 (1996) 1365-1374
160. Strelkov S.V., Herrmann H., and Aebi U. Molecular architecture of intermediate filaments. BioEssays 25 (2003) 243-251
161. Strelkov S.V., Kreplak L., Herrmann H., and Aebi U. Intermediate filament protein structure determination. Methods Cell Biol. 78 (2004) 25-43
162. Sugawara M., Kato K., Komatsu M., Wada C., Kawamura K., Shindo P.S., Yoshioka P.N., Tanaka K., Watanabe S., and Toyoshima I. A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates. Neurology 55 (2000) 986-990
163. Toivola D.M., Tao G.Z., Habtezion A., Liao J., and Omary M.B. Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol. 15 (2005) 608-617
164. Tomkins J., Usher P., Slade J.Y., Ince P.G., Curtis A., Bushby K., and Shaw P.J. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). NeuroReport 9 (1998) 3967-3970
165. Tomonaga M., Saito M., Yoshimura M., Shimada H., and Tohgi H. Ultrastructure of the Bunina bodies in anterior horn cells of amyotrophic lateral sclerosis. Acta Neuropathol. (Berl) 42 (1978) 81-86
166. Troy C.M., Brown K., Greene L.A., and Shelanski M.L. Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo. Neuroscience 36 (1990) 217-237
167. Troy C.M., Muma N.A., Greene L.A., Price D.L., and Shelanski M.L. Regulation of peripherin and neurofilament expression in regenerating rat motor neurons. Brain Res. 529 (1990) 232-238
168. Tu P.H., Gurney M.E., Julien J.P., Lee V.M., and Trojanowski J.Q. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab. Invest. 76 (1997) 441-456
169. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., and Lee V.M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3155-3160
170. Wagner O.I., Lifshitz J., Janmey P.A., Linden M., McIntosh T.K., and Leterrier J.F. Mechanisms of mitochondria-neurofilament interactions. J. Neurosci. 23 (2003) 9046-9058
171. Wang L., Ho C.L., Sun D., Liem R.K., and Brown A. Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat. Cell Biol. 2 (2000) 137-141
172. Wharton S., and Ince P.G. Pathology of Motor Neuron Disorders. In: Shaw P.J., and Strong M.J. (Eds). Motor Neuron Disorders, Blue Books of Practical Neurology (2003), Butterworth Heinemann, Philadelphia 17-49
173. Williamson T.L., Bruijn L.I., Zhu Q., Anderson K.L., Anderson S.D., Julien J.P., and Cleveland D.W. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9631-9636
174. Williamson T.L., and Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2 (1999) 50-56
175. Wong J., and Oblinger M.M. Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons. J. Neurosci. Res. 27 (1990) 332-341
176. Wong N.K., He B.P., and Strong M.J. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J. Neuropathol. Exp. Neurol. 59 (2000) 972-982
177. Xia C.H., Roberts E.A., Her L.S., Liu X., Williams D.S., Cleveland D.W., and Goldstein L.S. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 161 (2003) 55-66
178. Yin X., Crawford T.O., Griffin J.W., Tu P., Lee V.M., Li C., Roder J., and Trapp B.D. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 18 (1998) 1953-1962
179. Yoshihara T., Yamamoto M., Hattori N., Misu K., Mori K., Koike H., and Sobue G. Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals. J. Peripher. Nerv. Syst. 7 (2002) 221-224
180. Zhang B., Tu P., Abtahian F., Trojanowski J.Q., and Lee V.M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139 (1997) 1307-1315
181. Zuchner S., Vorgerd M., Sindern E., and Schroder J.M. The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy. Neuromuscul. Disord. 14 (2004) 147-157